Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Shares Outstanding (Diluted Average) (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $37.8 million as the latest value for Q3 2019.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 2.21% to $37.8 million in Q3 2019 year-over-year; TTM through Sep 2019 was $37.8 million, a 2.21% increase, with the full-year FY2018 number at $36.5 million, up 4.89% from a year prior.
  • Shares Outstanding (Diluted Average) was $37.8 million for Q3 2019 at Harvard Bioscience, roughly flat from $37.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $37.8 million in Q3 2019 to a low of $32.9 million in Q1 2015.
  • A 5-year average of $35.1 million and a median of $34.7 million in 2017 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): fell 0.05% in 2015, then grew 6.15% in 2019.
  • Harvard Bioscience's Shares Outstanding (Diluted Average) stood at $33.6 million in 2015, then increased by 1.84% to $34.2 million in 2016, then rose by 1.58% to $34.8 million in 2017, then increased by 4.89% to $36.5 million in 2018, then grew by 3.6% to $37.8 million in 2019.
  • Per Business Quant, the three most recent readings for HBIO's Shares Outstanding (Diluted Average) are $37.8 million (Q3 2019), $37.7 million (Q2 2019), and $37.6 million (Q1 2019).